How Ric Sinclair will drive growth at Cotiviti as CEO. March 09, 2026 Healthcare data leader Cotiviti names Ric Sinclair as CEO, succeeding Dr. Emad Rizk to accelerate platform innovation and payer efficiency Cotiviti, a prominent player in healthcare software and data-driven technology, has announced a strategic leadership transition aimed at bolstering its platform innovation and market growth. Ric Sinclair, a seasoned executive in the healthcare technology space, is set to join the company as CEO and a member of the Board of Directors on 16 March 2026. The move comes as the insurance and healthcare sectors increasingly rely on sophisticated data analytics to manage rising costs and operational complexities. Ric joins from Waystar, where he served as Chief Business Officer, bringing a track record of scaling enterprise-grade technology platforms. A legacy of integration and scale. Sinclair succeeds Emad Rizk, M.D., who is transitioning from his role as CEO, President and Chairman to become a Senior Advisor to the Board of Directors and Executive Team. Over a 10 year tenure, Emad has led the company through a period of significant evolution, oversaw transformational acquisitions and strengthened the firm's position in the payer market. Working alongside private equity partners Veritas and KKR, Emad oversaw the successful integration of Edifecs. This move significantly enhanced the company's interoperability capabilities, allowing health insurers and providers to better address quality gaps, cost pressures and operational complexity. "Leading Cotiviti has been a privilege," says Emad. "I am thankful for the dedication of the senior leadership team and the commitment of its owner-employees. Together, InsurTech Digital built a resilient foundation and cultivated a culture built on respect and excellence, all supported by collaboration and purpose. "I am confident the organisation is well positioned to continue delivering meaningful impact across the healthcare ecosystem. With Ric Sinclair's appointment as CEO, I believe his expertise and vision make him exceptionally qualified to guide Cotiviti into the next chapter, focused on supporting a more efficient and effective healthcare system." Focusing on the next era of innovation. For the InsurTech sector, the appointment of Ric - a leader with deep experience in commercial product design and operational rigor - signals a continued shift towards scalable, automated solutions for medical and administrative challenges. His background in driving value creation aligns with the company's current strategy to expand its digital footprint. "I'm excited to join Cotiviti at a defining moment in its journey," says Ric. "With our exceptional team and solid foundation, we are uniquely positioned to shape the next era of healthcare innovation. My priority is to accelerate this transformation - unlocking efficiency, reducing complexity and delivering measurable improvements across both medical and administrative challenges for all stakeholders in healthcare." Strengthening the payer-provider link. By leveraging its data-driven technology, Cotiviti aims to help payers navigate the complexities of a shifting regulatory and economic landscape. The appointment is expected to sharpen the company's focus on sustainable value creation for its clients. As insurers look to reduce friction in their operations, the emphasis on platform-led innovation will be central to the company's roadmap. Ric continues: "I'm excited to join Cotiviti at a defining moment in its journey. With our exceptional team and solid foundation, we are uniquely positioned to shape the next era of healthcare innovation." Executives. * Dr. Emad Rizk President, Chairman of the Board and outgoing CEO * Ric Sinclair Incoming CEO Company portals.

Waystar, a healthcare payment software provider, has expanded its collaboration with Google Cloud to advance AI capabilities in revenue cycle management. The partnership integrates Google's Gemini models and data infrastructure into Waystar's platform, which processes data from over one million providers. Waystar's AltitudeAI combines proprietary financial and clinical data with generative and agentic AI embedded in revenue cycle workflows. Since launching the partnership in early 2024, the company has prevented over $15 billion in denied claims and reduced denial appeal time by 90%. The expanded collaboration aims to accelerate development of autonomous revenue cycle capabilities, enabling self-learning systems that continuously improve authorisation, coverage identification and denial prevention. Waystar processes over 7.5 billion healthcare payment transactions annually, including $2.4 trillion in gross claims.

Waystar, a healthcare revenue cycle software company, reported Q4 revenue of $304 million, up 24% year-over-year, with 12% organic growth. Full-year 2025 revenue reached $1.1 billion, growing 17% annually. The company completed its acquisition of Iodine Software, adding over 1,000 hospitals and expanding its addressable market. Iodine contributed $31 million in Q4, slightly exceeding expectations. Integration is ahead of schedule, with over 90% of cost synergies expected to be realised in fiscal 2026. Waystar's AI platform, Altitude AI, prevented $15 billion in denials for clients in 2025 and reduced appeal times by 90%. The company added 85 clients with trailing twelve-month spend above $100,000, more than double the previous quarter. Net revenue retention reached 112%. Adjusted EBITDA hit $129 million, up 29% year-over-year, with a margin of 42.5%, exceeding the company's 40% long-term target.